Share：
Share this content in WeChat
X
[Chinese] [PDF] 568 1
• Review •
Application of cardiac magnetic resonance in risk stratification and prognostic evaluation of acute myocarditis
ZOU Yuting  WANG Cuiyan 

Cite this article as: ZOU Y T, WANG C Y. Application of cardiac magnetic resonance in risk stratification and prognostic evaluation of acute myocarditis[J]. Chin J Magn Reson Imaging, 2025, 16(9): 203-208. DOI:10.12015/issn.1674-8034.2025.09.031.


[Abstract] Acute myocarditis is triggered by multiple factors including infection, immunity, and drugs, with highly heterogeneous clinical manifestations ranging from asymptomatic presentations to severe arrhythmias, cardiogenic shock, and even death. The extent of cardiac involvement serves as a key determinant of patient prognosis; thus, accurate assessment of cardiac involvement is critical for prognostic evaluation and risk stratification in patients with acute myocarditis. Cardiac magnetic resonance imaging technology, with its unique advantage of multi-parameter imaging, shows significant value in cardiac assessment. Among these techniques, cine imaging enables non-invasive evaluation of cardiac morphology and function; late gadolinium enhancement can provide more precise anatomical and pathological information of myocardial tissue; and mapping techniques can reflect changes in myocardial tissue composition and the degree of edema. These techniques quantify the extent of cardiac involvement from multiple dimensions, including cardiac structure, function, and tissue characteristics, providing an important basis for prognostic evaluation and risk stratification of diseases. This review aims to summarize the research progress in the application of cardiac magnetic resonance in risk stratification and prognostic evaluation of patients with acute myocarditis, highlight the limitations of existing studies, and suggest potential future research directions. It aims to provide clinicians with more accurate non-invasive prognostic prediction tools to guide individualized treatment decisions and improve patients' long-term outcomes.
[Keywords] acute myocarditis；cardiac magnetic resonance；magnetic resonance imaging；prognosis；risk stratification

ZOU Yuting   WANG Cuiyan*  

Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China

Corresponding author: WANG C Y, E-mail: wcyzhang@163.com

Conflicts of interest   None.

Received  2025-07-23
Accepted  2025-08-28
DOI: 10.12015/issn.1674-8034.2025.09.031
Cite this article as: ZOU Y T, WANG C Y. Application of cardiac magnetic resonance in risk stratification and prognostic evaluation of acute myocarditis[J]. Chin J Magn Reson Imaging, 2025, 16(9): 203-208. DOI:10.12015/issn.1674-8034.2025.09.031.

[1]
LAMPEJO T, DURKIN S M, BHATT N, et al. Acute myocarditis: aetiology, diagnosis and management[J/OL]. Clin Med, 2021, 21(5): e505-e510 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/34507935/. DOI: 10.7861/clinmed.2021-0121.
[2]
The Joint Committee of Cardiomyopathy Specialty Alliance, National Center for Cardiovascular Diseases, Cardiovascular Precision Medicine Branch of China International Exchange, Promotive Association for Medical. 2024 guideline for diagnosis and treatment of adult patients with myocarditis[J]. Chin Circ J, 2024, 39(6): 521-536. DOI: 10.3969/j.issn.1000-3614.2024.06.001.
[3]
ZAFEIRI M, KNOTT K, LAMPEJO T. Acute myocarditis: an overview of pathogenesis, diagnosis and management[J]. Panminerva Med, 2024, 66(2): 174-187. DOI: 10.23736/S0031-0808.24.05042-0.
[4]
WALTER K. What is acute myocarditis?[J/OL]. Jama, 2023, 330(6): 574 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/37552301/. DOI: 10.1001/jama.2023.5526.
[5]
NARDUCCI M L, BALLACCI F, GIORDANO F, et al. Sudden cardiac death after acute myocarditis with arrhythmic presentation: hunting for risk predictors - a systematic review and meta-analysis[J/OL]. Open Heart, 2024, 11(2): e002985 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/39882569/. DOI: 10.1136/openhrt-2024-002985.
[6]
HARRIS K M, MACKEY-BOJACK S, BENNETT M, et al. Sudden unexpected death due to myocarditis in young people, including athletes[J/OL]. Am J Cardiol, 2021, 143: 131-134 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/33347841/. DOI: 10.1016/j.amjcard.2020.12.028.
[7]
YUKCU B, AYDEMIR M M, BALCI M, et al. Baseline and follow-up cardiac magnetic resonance imaging findings in children with acute myocarditis and factors associated with late gadolinium enhancement[J/OL]. J Clin Med, 2024, 14(1): 189 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/39797272/. DOI: 10.3390/jcm14010189.
[8]
AMMIRATI E, BUONO A, MORONI F, et al. State-of-the-art of endomyocardial biopsy on acute myocarditis and chronic inflammatory cardiomyopathy[J]. Curr Cardiol Rep, 2022, 24(5): 597-609. DOI: 10.1007/s11886-022-01680-x.
[9]
HUANG F, AMMIRATI E, PONNAIAH M, et al. Fulminant myocarditis proven by early biopsy and outcomes[J]. Eur Heart J, 2023, 44(48): 5110-5124. DOI: 10.1093/eurheartj/ehad707.
[10]
BOHBOT Y, PEZEL T, DEMIRKıRAN A, et al. European Association of Cardiovascular Imaging survey on cardiovascular multimodality imaging in acute myocarditis[J]. Eur Heart J Cardiovasc Imaging, 2024, 25(7): 892-900. DOI: 10.1093/ehjci/jeae092.
[11]
ADEBOYE A, ALKHATIB D, BUTT A, et al. A review of the role of imaging modalities in the evaluation of viral myocarditis with a special focus on COVID-19-related myocarditis[J/OL]. Diagnostics (Basel), 2022, 12(2): 549 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/35204637/. DOI: 10.3390/diagnostics12020549.
[12]
PERETTO G, MERLO M, GENTILE P, et al. Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy[J]. Clin Res Cardiol, 2023, 112(3): 392-400. DOI: 10.1007/s00392-022-02103-1.
[13]
ZAINAL H, ROLF A, ZHOU H, et al. Comparison of diagnostic algorithms in clinically suspected viral myocarditis: Agreement between cardiovascular magnetic resonance, endomyocardial biopsy, and troponin T[J/OL]. J Cardiovasc Magn Reson, 2024, 26(2): 101087 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/39191369/. DOI: 10.1016/j.jocmr.2024.101087.
[14]
GENTILE P, MERLO M, PERETTO G, et al. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias[J]. Eur J Heart Fail, 2021, 23(12): 2045-2054. DOI: 10.1002/ejhf.2288.
[15]
PIERONI M, CIABATTI M, ZOCCHI C, et al. Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis[J/OL]. Int J Cardiol, 2024, 397: 131603 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/37979787/. DOI: 10.1016/j.ijcard.2023.131603.
[16]
BERNHARD B, MARXER M E, ZURKIRCHEN J C, et al. Prognostic implications of clinical and imaging diagnostic criteria for myocarditis[J]. J Am Coll Cardiol, 2024, 84(15): 1373-1387. DOI: 10.1016/j.jacc.2024.07.018.
[17]
SANGUINETI F, GAROT P, MANA M, et al. Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis[J/OL]. J Cardiovasc Magn Reson, 2015, 17(1): 78 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/26318624/. DOI: 10.1186/s12968-015-0185-2.
[18]
BOHBOT Y, GAROT J, HOVASSE T, et al. Clinical and cardiovascular magnetic resonance predictors of early and long-term clinical outcome in acute myocarditis[J/OL]. Front Cardiovasc Med, 2022, 9: 886607 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/35571177/. DOI: 10.3389/fcvm.2022.886607.
[19]
SONG W H, ZHANG N, LV T L, et al. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: a systematic review and meta-analysis[J/OL]. Cancer Innov, 2024, 3(3): e109 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/38947756/. DOI: 10.1002/cai2.109.
[20]
BONANNI M, ANGELINI G, LEO L A, et al. Multimodality imaging evaluation to detect subtle right ventricular involvement in patients with acute myocarditis and preserved left ventricular ejection fraction[J/OL]. J Clin Med, 2023, 12(13): 4308 [2025-06-20]. https://www.mdpi.com/2077-0383/12/13/4308.. DOI: 10.3390/jcm12134308.
[21]
ÖZDEN Ö, ÜNLÜ S, ŞAHIN A A, et al. Cardiac magnetic resonance speckle tracking analysis of right ventricle function in myocarditis with preserved right ventricular ejection fraction[J/OL]. Medicina (Kaunas), 2024, 60(10): 1569 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/39459355/. DOI: 10.3390/medicina60101569.
[22]
ZHU L Y, ZHANG H Y, JIANG M D, et al. Right ventricular strain improves cardiac MRI-based prognostication in heart failure with preserved ejection fraction[J/OL]. Radiology, 2025, 315(3): e243080 [2025-07-25]. https://pubmed.ncbi.nlm.nih.gov/40525977/. DOI: 10.1148/radiol.243080.
[23]
MATTEI A, STRUMIA A, BENEDETTO M, et al. Perioperative right ventricular dysfunction and abnormalities of the tricuspid valve apparatus in patients undergoing cardiac surgery[J/OL]. J Clin Med, 2023, 12(22): 7152 [2025-06-20]. https://www.mdpi.com/2077-0383/12/22/7152. DOI: 10.3390/jcm12227152.
[24]
BERNHARD B, SCHNYDER A, GARACHEMANI D, et al. Prognostic value of right ventricular function in patients with suspected myocarditis undergoing cardiac magnetic resonance[J]. JACC Cardiovasc Imaging, 2023, 16(1): 28-41. DOI: 10.1016/j.jcmg.2022.08.011.
[25]
HOUARD L, MILITARU S, TANAKA K, et al. Test-retest reliability of left and right ventricular systolic function by new and conventional echocardiographic and cardiac magnetic resonance parameters[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(10): 1157-1167. DOI: 10.1093/ehjci/jeaa206.
[26]
FISCHER K, OBRIST S J, ERNE S A, et al. Feature tracking myocardial strain incrementally improves prognostication in myocarditis beyond traditional CMR imaging features[J]. JACC Cardiovasc Imaging, 2020, 13(9): 1891-1901. DOI: 10.1016/j.jcmg.2020.04.025.
[27]
SOEIRO A M, BOSSA A S, CÉSAR M C, et al. The association of myocardial strain with cardiac magnetic resonance and clinical outcomes in patients with acute myocarditis[J/OL]. Front Cardiovasc Med, 2023, 10: 1121083 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/37588035/. DOI: 10.3389/fcvm.2023.1121083.
[28]
LEE J W, JEONG Y J, LEE G, et al. Predictive value of cardiac magnetic resonance imaging-derived myocardial strain for poor outcomes in patients with acute myocarditis[J]. Korean J Radiol, 2017, 18(4): 643-654. DOI: 10.3348/kjr.2017.18.4.643.
[29]
VOS J L, RAAFS A G, VAN DER VELDE N, et al. Comprehensive cardiovascular magnetic resonance-derived myocardial strain analysis provides independent prognostic value in acute myocarditis[J/OL]. J Am Heart Assoc, 2022, 11(19): e025106[2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/36129042/. DOI: 10.1161/JAHA.121.025106.
[30]
PORCARI A, MERLO M, BAGGIO C, et al. Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF[J/OL]. Eur J Clin Invest, 2022, 52(10): e13815 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/35598175/. DOI: 10.1111/eci.13815.
[31]
ZHAO S H, YUN H, CHEN C Z, et al. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis[J]. Eur Radiol, 2022, 32(11): 7657-7667. DOI: 10.1007/s00330-022-08844-x.
[32]
CAU R, PISU F, SURI J S, et al. Atrial and ventricular strain imaging using CMR in the prediction of ventricular arrhythmia in patients with myocarditis[J/OL]. J Clin Med, 2024, 13(3): 662 [2025-06-20]. http://www.mdpi.com/2077-0383/13/3/662. DOI: 10.3390/jcm13030662.
[33]
LEE J M, CHOO K S, JEONG Y J, et al. Left atrial strain derived from cardiac magnetic resonance imaging can predict outcomes of patients with acute myocarditis[J]. Korean J Radiol, 2023, 24(6): 512-521. DOI: 10.3348/kjr.2022.0898.
[34]
RHEE E, DOBRILA J, KAUR H, et al. Right and left ventricular cardiac magnetic resonance imaging derived peak systolic strain is abnormal in children with myocarditis[J]. Int J Cardiovasc Imaging, 2024, 40(1): 139-147. DOI: 10.1007/s10554-023-02975-y.
[35]
BERNHARD B, TANNER G, GARACHEMANI D, et al. Predictive value of cardiac magnetic resonance right ventricular longitudinal strain in patients with suspected myocarditis[J/OL]. J Cardiovasc Magn Reson, 2023, 25(1): 49 [2025-06-20]. http://linkinghub.elsevier.com/retrieve/pii/S1097664723000492. DOI: 10.1186/s12968-023-00957-6.
[36]
GRÄNI C, EICHHORN C, BIÈRE L, et al. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis[J/OL]. J Cardiovasc Magn Reson, 2019, 21(1): 14 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/30813942/. DOI: 10.1186/s12968-019-0520-0.
[37]
GRÜN S, SCHUMM J, GREULICH S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery[J]. J Am Coll Cardiol, 2012, 59(18): 1604-1615. DOI: 10.1016/j.jacc.2012.01.007.
[38]
GRÄNI C, EICHHORN C, BIÈRE L, et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis[J]. J Am Coll Cardiol, 2017, 70(16): 1964-1976. DOI: 10.1016/j.jacc.2017.08.050.
[39]
POPA A, CIONCA C, AGOSTON R, et al. The role of magnetic resonance imaging in risk stratification of patients with acute myocarditis[J/OL]. Diagnostics (Basel), 2024, 14(13): 1426 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/39001316/. DOI: 10.3390/diagnostics14131426.
[40]
CHOPRA H, ARANGALAGE D, BOULETI C, et al. Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis[J/OL]. Int J Cardiol, 2016, 212: 63-69 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/27035605/. DOI: 10.1016/j.ijcard.2016.03.004.
[41]
ISAAK A, WIRTZ J, KRAVCHENKO D, et al. Cardiac MRI in infarct-like myocarditis: transmural extension of late gadolinium enhancement is associated with worse outcomes[J/OL]. Insights Imaging, 2024, 15(1): 246 [2025-06-20]. http://insightsimaging.springeropen.com/articles/10.1186/s13244-024-01832-3. DOI: 10.1186/s13244-024-01832-3.
[42]
NEDELJKOVIC-ARSENOVIC O, RISTIĆ A, ĐORĐEVIĆ N, et al. Cardiac magnetic resonance imaging as a risk stratification tool in COVID-19 myocarditis[J/OL]. Diagnostics (Basel), 2024, 14(8): 790 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/38667436/. DOI: 10.3390/diagnostics14080790.
[43]
LI J H, XU X Q, ZHU Y J, et al. Subendocardial involvement as an underrecognized cardiac MRI phenotype in myocarditis[J]. Radiology, 2022, 302(1): 61-69. DOI: 10.1148/radiol.2021211276.
[44]
JIANG L Y, ZUO H J, LIU J B, et al. The pattern of late gadolinium enhancement by cardiac MRI in fulminant myocarditis and its prognostic implication: a two-year follow-up study[J/OL]. Front Cardiovasc Med, 2023, 10: 1144469 [2025-06-20]. http://www.frontiersin.org/articles/10.3389/fcvm.2023.1144469/full. DOI: 10.3389/fcvm.2023.1144469.
[45]
LIU F Y, GAO Y, WANG W X, et al. Prognostic value of myocardial signal intensity heterogeneity based on late gadolinium enhancement in cardiac magnetic resonance in patients with myocarditis[J]. Chin J Magn Reson Imag, 2024, 15(3): 68-73. DOI: 10.12015/issn.1674-8034.2024.03.012.
[46]
KARAMITSOS T D, ARVANITAKI A, KARVOUNIS H, et al. Myocardial tissue characterization and fibrosis by imaging[J]. JACC Cardiovasc Imaging, 2020, 13(5): 1221-1234. DOI: 10.1016/j.jcmg.2019.06.030.
[47]
TIAN Y T, WANG T, TIAN L W, et al. Early detection and serial monitoring during chemotherapy-radiation therapy: Using T1 and T2 mapping cardiac magnetic resonance imaging[J/OL]. Front Cardiovasc Med, 2023, 10: 1085737 [2025-06-20]. http://www.frontiersin.org/articles/10.3389/fcvm.2023.1085737/full. DOI: 10.3389/fcvm.2023.1085737.
[48]
GAIZAUSKIENE K, LEKETAITE K, GLAVECKAITE S, et al. Diagnostic value of cardiovascular magnetic resonance T1 and T2 mapping in acute myocarditis: a systematic literature review[J/OL]. Medicina (Kaunas), 2024, 60(7): 1162 [2025-06-20]. http://www.mdpi.com/1648-9144/60/7/1162. DOI: 10.3390/medicina60071162.
[49]
TREIBER J, NOVAK D, FISCHER-RASOKAT U, et al. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study[J/OL]. J Cardiovasc Magn Reson, 2023, 25(1): 8 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/36755275/. DOI: 10.1186/s12968-023-00918-z.
[50]
GRÄNI C, BIÈRE L, EICHHORN C, et al. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis[J]. Int J Cardiovasc Imaging, 2019, 35(6): 1067-1078. DOI: 10.1007/s10554-019-01552-6.
[51]
WANG Y N, DUAN X J, ZHU L Y, et al. Prognostic value of myocardial parametric mapping in patients with acute myocarditis: a retrospective study[J/OL]. Radiol Cardiothorac Imaging, 2025, 7(1): e240125 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/39912725/. DOI: 10.1148/ryct.240125.
[52]
SINIGIANI G, DE MICHIELI L, DE CONTI G, et al. Cardiac magnetic resonance-detected acute myocardial edema as predictor of favourable prognosis: a comprehensive review[J/OL]. J Cardiovasc Dev Dis, 2023, 10(8): 319 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/37623332/. DOI: 10.3390/jcdd10080319.
[53]
O'BRIEN A T, GIL K E, VARGHESE J, et al. T2 mapping in myocardial disease: a comprehensive review[J/OL]. J Cardiovasc Magn Reson, 2022, 24(1): 33 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/35659266/. DOI: 10.1186/s12968-022-00866-0.
[54]
SPIEKER M, HABERKORN S, GASTL M, et al. Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis[J/OL]. J Cardiovasc Magn Reson, 2016, 19(1): 38 [2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/28351402/. DOI: 10.1186/s12968-017-0350-x.
[55]
AQUARO G D, GHEBRU HABTEMICAEL Y, CAMASTRA G, et al. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis[J]. J Am Coll Cardiol, 2019, 74(20): 2439-2448. DOI: 10.1016/j.jacc.2019.08.1061.
[56]
POLIDORI T, DE SANTIS D, RUCCI C, et al. Radiomics applications in cardiac imaging: a comprehensive review[J]. Radiol Med, 2023, 128(8): 922-933. DOI: 10.1007/s11547-023-01658-x.
[57]
HU D L, CUI M M, ZHANG X K, et al. Using machine learning models based on cardiac magnetic resonance parameters to predict the prognostic in children with myocarditis[J/OL]. BMC Pediatr, 2025, 25(1): 412 [2025-06-20]. https://pubmed.ncbi.nlm.nih.gov/40410762/. DOI: 10.1186/s12887-025-05753-y.
[58]
STOECK C T, VON DEUSTER C, FUETTERER M, et al. Cardiovascular magnetic resonance imaging of functional and microstructural changes of the heart in a longitudinal pig model of acute to chronic myocardial infarction[J/OL]. J Cardiovasc Magn Reson, 2021, 23(1): 103[2025-06-20]. http://pubmed.ncbi.nlm.nih.gov/34538266/. DOI: 10.1186/s12968-021-00794-5.
[59]
OZKOK S, CIFTCI H O, KELES N, et al. Cardiac magnetic resonance T2* mapping in patients with COVID-19 pneumonia is associated with serum ferritin level?[J]. Int J Cardiovasc Imaging, 2023, 39(4): 821-830. DOI: 10.1007/s10554-022-02784-9.

PREV Progress in the application of MRI-based radiomics in esophageal cancer
NEXT Advances in imaging research for prognostic evaluation after hepatocellular carcinoma ablation therapy
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn